<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0036">
 <label>36.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Manns</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Samuel</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gane</surname>
    <given-names>EJ</given-names>
   </name>, 
   <etal>et al;</etal>
  </person-group>
  <person-group>
   <collab>SOLAR-2 Investigators</collab>
  </person-group>
  <article-title>Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial</article-title>. 
  <source>Lancet Infect Dis</source>
  <year>2016</year>; 
  <volume>16</volume>:
  <fpage>685</fpage>â€“
  <lpage>97</lpage>.
  <pub-id pub-id-type="pmid">26907736</pub-id>
 </mixed-citation>
</ref>
